Primecap Management Co. CA Purchases Shares of 9,250 Humana Inc. $HUM

Key Points

• Primecap Management acquired 9,250 Humana shares in the second quarter, valued at approximately $3.7 million. Institutional investors and hedge funds collectively own 92.38% of Humana’s outstanding stock.
• Analyst sentiment is mixed, with 14 Buy ratings, 15 Holds and one Sell rating; the consensus rating is Hold with a price target of $403.91.
• Humana reported quarterly earnings of $7.61 per share, exceeding estimates of $7.27, while revenue rose 26.2% year over year to $40.89 billion. Shares opened at $390.06, near the consensus target.

Primecap Management Co. CA acquired a new position in Humana Inc. (NYSE:HUM - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 9,250 shares of the insurance provider's stock, valued at approximately $3,674,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. BlackRock Inc. acquired a new stake in Humana during the second quarter worth approximately $4,138,160,000. Pzena Investment Management LLC acquired a new position in Humana in the second quarter valued at approximately $1,749,014,000. Capital International Investors lifted its stake in Humana by 113.9% in the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider's stock valued at $1,490,239,000 after buying an additional 3,097,571 shares during the period. Norges Bank bought a new position in shares of Humana during the 4th quarter worth approximately $456,632,000. Finally, Wellington Management Group LLP boosted its holdings in shares of Humana by 4,481.7% during the 4th quarter. Wellington Management Group LLP now owns 1,196,502 shares of the insurance provider's stock worth $306,460,000 after buying an additional 1,170,387 shares in the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the stock. Wolfe Research reiterated an "outperform" rating and issued a $450.00 price objective on shares of Humana in a research note on Monday. Robert W. Baird set a $390.00 target price on shares of Humana in a research note on Thursday, July 30th. Lake Street Capital assumed coverage on shares of Humana in a report on Thursday, July 30th. They issued a "buy" rating for the company. Cantor Fitzgerald lifted their price target on shares of Humana from $264.00 to $300.00 and gave the company a "neutral" rating in a research note on Tuesday, July 7th. Finally, Needham & Company LLC initiated coverage on shares of Humana in a report on Wednesday, May 20th. They set a "buy" rating on the stock. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $403.91.

Humana Stock Up 0.1%

Shares of NYSE HUM opened at $390.06 on Thursday. The stock has a market capitalization of $46.84 billion, a P/E ratio of 36.90, a P/E/G ratio of 2.22 and a beta of 0.72. The company has a 50-day moving average price of $384.44 and a 200-day moving average price of $286.38. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $428.88. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74.

Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. During the same period in the previous year, the firm posted $6.27 earnings per share. The firm's revenue for the quarter was up 26.2% on a year-over-year basis. On average, equities research analysts forecast that Humana Inc. will post 9.12 EPS for the current fiscal year.

Humana Profile

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source